(Q70656830)
Statements
Immunological and clinical effects of intramuscular rIFN alpha-2a and low dose subcutaneous rIL-2 in patients with advanced malignant melanoma (English)
G Castello
P Comella
T Manzo
A P Parziale
M G Galati
A Daponte
R Casaretti
E Celentano
1 February 1993